Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study
about
Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.Targeting the dopamine D3 receptor: an overview of drug design strategies.Synthesis and characterization of selective dopamine D₂ receptor ligands using aripiprazole as the lead compoundIdentifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.Comparison of the binding and functional properties of two structurally different D2 dopamine receptor subtype selective compounds.Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging.Reduction of cocaine self-administration and D3 receptor-mediated behavior by two novel dopamine D3 receptor-selective partial agonists, OS-3-106 and WW-III-55Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.Characterization of [(3) H]LS-3-134, a novel arylamide phenylpiperazine D3 dopamine receptor selective radioligand.Positron emission tomography imaging of dopamine D2 receptors using a highly selective radiolabeled D2 receptor partial agonist.Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands.PET radiotracer development for imaging high-affinity state of dopamine D2 and D3 receptors: Binding studies of fluorine-18 labeled aminotetralins in rodents.Challenges in the development of dopamine D2- and D3-selective radiotracers for PET imaging studies.In Vitro and In Vivo Characterization of Selected Fluorine-18 Labeled Radioligands for PET Imaging of the Dopamine D3 Receptor.Selectivity of probes for PET imaging of dopamine D3 receptors.
P2860
Q33697312-81E5B9C9-2EC8-48AD-92A8-9F0F1CF5100CQ34524556-CD84FA2F-49C8-40AF-B629-20BD56DD78E4Q35055114-421E4471-69ED-436F-A3C8-5CC1FFB5E66AQ35892818-733E9E8E-7175-42BE-8E96-BA15C33CB52EQ36219773-0F441987-53BB-4F73-85D8-0C99C67246D1Q36479708-D66EA405-0737-4768-B7E8-7B35136DC40DQ37117235-F3250F8F-55F0-494F-9807-CACB5ACB51C8Q37252065-708554AD-6CCB-42B9-8609-D416A90C352CQ37568555-5CA3D533-3FC8-4C65-A983-2F0ADE323AC8Q41993974-AB6CF56B-0F46-424B-871B-E15E89C41597Q41998180-B6A92C52-21D2-4A0E-B5BF-2D50D0CD7330Q42940046-755FE3C8-5BC2-4C67-AE6B-2D28D4548479Q45995692-748748D1-B974-4E97-A595-24E70AA04FD4Q48149406-A465B350-FD7C-407F-A9C4-120F5FA85291Q48534307-382E37DA-E5C1-4A40-ABBB-EC9198BDC0B1Q52316241-59A8D68C-A62C-4EA8-8876-052AE37E3B26
P2860
Endogenous dopamine (DA) competes with the binding of a radiolabeled D₃ receptor partial agonist in vivo: a positron emission tomography study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Endogenous dopamine (DA) compe ...... tron emission tomography study
@en
type
label
Endogenous dopamine (DA) compe ...... tron emission tomography study
@en
prefLabel
Endogenous dopamine (DA) compe ...... tron emission tomography study
@en
P2093
P2860
P50
P356
P1433
P1476
Endogenous dopamine (DA) compe ...... tron emission tomography study
@en
P2093
Michelle Taylor
Robert H Mach
Robert R Luedtke
Shihong Li
P2860
P304
P356
10.1002/SYN.20891
P577
2011-03-21T00:00:00Z